PMID: 15225857DOI: 10.1016/j.ijantimicag.2004.03.009Jul 1, 2004Paper
Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus?
International Journal of Antimicrobial Agents
Bo ShopsinKarl Drlica
Abstract
The use of quinolones in the treatment of non-serious community-acquired methicillin-resistant Staphylococcus aureus is discussed. The new C8-modified quinolones may be suitable for such treatment but controlled trials should be carried out to ensure that the pharmacokinetics are such that there is little risk of resistance developing.
References
Jun 1, 1991·The Journal of Infectious Diseases·H M BlumbergI K Wachsmuth
May 7, 1998·Archives of Internal Medicine·J M LindenmayerJ K Carney
Aug 11, 1998·The Journal of Infectious Diseases·P M AdcockT V Murphy
Nov 26, 1999·The Pediatric Infectious Disease Journal·A L FrankP C Schreckenberger
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E J GorakJ D Brown
Jun 20, 2000·Antimicrobial Agents and Chemotherapy·J L Martinez, F Baquero
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S HarbarthD Pittet
Mar 15, 2001·Diagnostic Microbiology and Infectious Disease·R N JonesUNKNOWN SENTRY Antimicrobial Surveillance Program Participants Group
Jul 14, 2001·Antimicrobial Agents and Chemotherapy·G A TarshisM J Brown
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·X Zhao, K Drlica
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B R Levin
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·L F DiscottoJ F Barrett
Oct 27, 2001·The Journal of Antimicrobial Chemotherapy·J Fung-TomcE Gradelski
Dec 26, 2001·The Journal of Antimicrobial Chemotherapy·T M A WellerR Wise
Jan 31, 2002·American Journal of Clinical Dermatology·Joseph M Blondeau
Feb 28, 2002·The Journal of Infectious Diseases·Xilin Zhao, Karl Drlica
Mar 19, 2002·Antimicrobial Agents and Chemotherapy·Xiao Xue MaKeiichi Hiramatsu
Aug 17, 2002·The Pediatric Infectious Disease Journal·Arthur L FrankJohn P Quinn
Oct 29, 2002·The Journal of Infectious Diseases·Robert S DaumSusan Boyle-Vavra
Nov 1, 2002·Journal of Clinical Microbiology·Keiko OkumaKeiichi Hiramatsu
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cassandra D SalgadoDavid P Calfee
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Xilin ZhaoKarl Drlica
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·Alexander A FirsovStephen H Zinner
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bo ShopsinBarry N Kreiswirth
Sep 3, 2003·The Journal of Antimicrobial Chemotherapy·Stephen H ZinnerAlexander A Firsov
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa SaimanPhyllis Della-Latta
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Erica S PanFrançoise Perdreau-Remington
❮ Previous
Next ❯
Citations
Feb 2, 2006·Current Infectious Disease Reports·Matthew E Levison, Shirley Fung
Dec 27, 2011·Injury·M Morgan
Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey
Feb 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stan Deresinski
Oct 12, 2010·The Journal of Antimicrobial Chemotherapy·Matthew S Dryden
Oct 17, 2007·Antimicrobial Agents and Chemotherapy·Kazuki HoshinoTsuyoshi Otani
Oct 26, 2012·Interdisciplinary Perspectives on Infectious Diseases·Axel Dalhoff
Mar 31, 2012·Infection·A Dalhoff
Nov 23, 2006·The Medical Clinics of North America·Burke A Cunha
Jan 12, 2007·International Journal of Dermatology·Philip R Cohen
Jan 21, 2006·International Journal of Antimicrobial Agents·Helen C Maltezou, Helen Giamarellou
Jun 1, 2006·The Annals of Pharmacotherapy·Kathryn E SabolJames S Lewis
Jan 11, 2005·Current Opinion in Infectious Diseases·Gregory M Anstead, Aaron D Owens
Nov 1, 2005·Current Opinion in Infectious Diseases·Michael W Ellis, James S Lewis
Jun 9, 2007·The Journal of Antimicrobial Chemotherapy·A A VickersI Chopra
May 11, 2011·Neuropsychological Rehabilitation·Jennifer D RyanCarolyn M Baum
Mar 16, 2007·Expert Opinion on Emerging Drugs·Emma J Bishop, Benjamin P Howden
❮ Previous
Next ❯
Related Concepts
Related Feeds
CRISPR & Staphylococcus
CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.
Related Papers
The New England Journal of Medicine
Loren G MillerBrad Spellberg
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
John S FrancisJohn G Bartlett
Annals of Internal Medicine
Robert C Moellering
The Journal of Infection
B M W Diederen, J A J W Kluytmans